ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,364Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 22

$392K Total Retail Price of All Prescriptions

Rank: 8 out of 22

252 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

23% of this provider’s 252 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

13% of this provider’s 252 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 9,206 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 521 496 1 1
FUROSEMIDE 487 487 2 4
POTASSIUM CHLORIDE 374 374 3 13
LISINOPRIL 360 349 4 2
DONEPEZIL HCL 315 315 5 9
MIRTAZAPINE 252 252 6 24
SPIRONOLACTONE 227 227 7 48
WARFARIN SODIUM 214 214 8 8
METOPROLOL TARTRATE 196 196 9 7
OMEPRAZOLE 178 178 10 6
PAROXETINE HCL 174 174 11 68
NAMENDA 168 164 12 17
HYDROCHLOROTHIAZIDE 160 147 13 15
RISPERIDONE 158 158 14 28
AMLODIPINE BESYLATE 131 131 15 5
PREDNISONE 129 129 16 35
DIGOXIN 119 119 17 45
ATENOLOL 114 114 18 12
OXYCODONE-ACETAMINOPHEN 113 113 S2 19 39
SIMVASTATIN 104 90 20 3
HYDROCODONE-ACETAMINOPHEN 104 104 S3 20 16
METOPROLOL SUCCINATE 104 104 20 19
SPIRIVA 102 102 23 52
CITALOPRAM HBR 99 99 24 10
CARBIDOPA-LEVODOPA 95 95 25 49
SERTRALINE HCL 94 93 26 20
PANTOPRAZOLE SODIUM 92 92 27 29
TAMSULOSIN HCL 88 87 28 33
FAMOTIDINE 86 86 29 56
GABAPENTIN 86 85 29 14
QUETIAPINE FUMARATE 84 76 31 21
METFORMIN HCL 79 79 32 11
OXYCONTIN 77 77 S2 33 97
GLIPIZIDE 76 76 34 30
DIVALPROEX SODIUM 72 45 35 36
METOLAZONE 70 70 36 106
PRAVASTATIN SODIUM 70 70 36 26
CARVEDILOL 67 67 38 38
ALBUTEROL SULFATE 61 61 39 84
ALENDRONATE SODIUM 55 55 40 23
ALLOPURINOL 54 54 41 40
NITROGLYCERIN PATCH 51 51 42 125
LUMIGAN 50 50 43 129
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.